Institute Of Hematology & Blood Diseases Hospital, China

This study tests whether a transplant of umbilical cord blood can slow the progression of ALS, a fast-moving nerve disease. The idea is that the transplant may calm harmful inflammation in the brain and spinal cord. Eight adults with early-stage ALS will receive the transplant an…

This study compares two different chemotherapy combinations for adults aged 60-75 who are newly diagnosed with acute myeloid leukemia (AML) and healthy enough for strong treatment. The goal is to see which regimen works better and is safer. About 113 participants will be randomly…

This study tested whether the drug daratumumab can eliminate tiny amounts of leukemia cells that remain after standard chemotherapy in adults with T-cell acute lymphoblastic leukemia (T-ALL). These remaining cells, called minimal residual disease (MRD), raise the risk of the canc…

This study tests a new treatment for people with relapsed or hard-to-treat B-cell non-Hodgkin lymphoma. It combines two therapies: a bispecific antibody and CAR-T cells, aiming to improve effectiveness. The study will check safety and how well the treatment controls the cancer. A…

This study tests a combination of three drugs (obinutuzumab, zanubrutinib, and lenalidomide) followed by a short course of chemotherapy for people newly diagnosed with mantle cell lymphoma, a rare blood cancer. The goal is to see if this approach can shrink tumors and reduce canc…

This study tests whether a new combination of chemotherapy drugs (HAV) works better than another combo (DAV/IAV) for adults aged 60-75 with acute myeloid leukemia (AML). About 41 participants will receive one of the two treatments to see which leads to longer remission and surviv…

This study tested a new treatment called BCMA CAR-T cell therapy for people with a high-risk type of multiple myeloma that still showed signs of disease after a stem cell transplant. The goal was to see if the therapy could safely eliminate remaining cancer cells. However, the st…

This study aimed to test a drug called CM-336 in people with AL amyloidosis, a rare disease where abnormal proteins build up in organs. The drug is a bispecific antibody that helps the immune system attack harmful cells. The trial was withdrawn before enrolling any participants, …

This study tests a drug called inotuzumab ozogamicin in adults with a type of leukemia (Ph-negative ALL) who still have tiny amounts of cancer cells left after initial chemotherapy. The goal is to see if the drug can wipe out those leftover cells. About 31 participants will recei…

This study aimed to see if measuring a specific gene change (c-Kit mutation) in blood or bone marrow could help predict if acute myeloid leukemia (AML) will come back after treatment. Researchers planned to follow AML patients with this mutation and compare the new test with stan…

This study is gathering information from 500 male patients aged 12 and older with severe hemophilia A or B in China. Researchers are measuring the disease's burden, treatment costs, and how care varies across different regions and centers. The goal is to identify gaps in care and…

This study follows 2,000 people who stored umbilical cord blood in a bank in Tianjin, China. Researchers will check their health over time to see how storing cord blood relates to future health. No treatment or intervention is given—it is purely an observational study.